tiprankstipranks
Upstream Bio, Inc. (UPB)
NASDAQ:UPB
US Market
UPB
Upstream Bio, Inc.
RESEARCH TOOLSreports

Upstream Bio, Inc. (UPB) Financial Statements

Compare
260 Followers

Upstream Bio, Inc. Financial Overview

Upstream Bio, Inc.'s market cap is currently $529.04M. The company's EPS TTM is $-0.786; its P/E ratio is -10.19; Upstream Bio, Inc. is scheduled to report earnings on March 18, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 2.85M$ 2.37M$ 2.38M$ 1.21M
Gross Profit$ 0.00$ 2.37M$ 2.38M$ 1.21M
Operating Income$ -160.36M$ -77.76M$ -40.11M$ -23.91M
EBITDA$ -160.36M$ -77.67M$ -40.05M$ -23.90M
Net Income$ -143.44M$ -62.81M$ -20.54M$ -23.87M
Balance Sheet
Cash & Short-Term Investments$ 341.51M$ 470.45M$ 109.81M$ 17.05M
Total Assets$ 353.77M$ 481.72M$ 117.20M$ 18.48M
Total Debt$ 1.27M$ 1.83M$ 45.00K$ 94.00K
Net Debt$ -100.31M$ -324.06M$ -25.79M$ -16.96M
Total Liabilities$ 14.00M$ 11.87M$ 240.32M$ 124.63M
Stockholders' Equity$ 339.77M$ 469.85M$ -123.13M$ -106.16M
Cash Flow
Free Cash Flow$ -133.28M$ -59.68M$ -38.07M$ -19.10M
Operating Cash Flow$ -133.28M$ -59.17M$ -37.93M$ -19.02M
Investing Cash Flow$ -93.48M$ -59.48M$ -82.84M$ -82.00K
Financing Cash Flow$ 2.44M$ 418.91M$ 129.55M$ 9.96M
Currency in USD

Upstream Bio, Inc. Earnings and Revenue History

Income Statement >

Upstream Bio, Inc. Debt to Assets

Balance Sheet >

Upstream Bio, Inc. Cash Flow

Cash Flow >

Upstream Bio, Inc. Forecast EPS vs Actual EPS

Earnings >